| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jerome Sarris, Justin Sinclair, Diana Karamacoska, Maggie Davidson, Joseph Firt. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:31948424. |
medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. |
2020-12-21 |
2023-08-13 |
Not clear |
| Kuhilan Gounder, Janavi Dunuwille, John Dunne, Judy Lee, Peter Silbert, Nicholas Law. The other side of the leaf: Seizures associated with synthetic cannabinoid use. Epilepsy & behavior : E&B. vol 104. issue Pt A. 2020-12-07. PMID:31958643. |
there has recently been a marked rise in the medicinal use of cannabis for epilepsy and multiple other conditions. |
2020-12-07 |
2023-08-13 |
Not clear |
| b' Chiara Pane, Francesco Sacc\\xc3\\xa. The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 41. issue 3. 2020-11-30. PMID:31776867.' |
the use of medical grade cannabis in italy for drug-resistant epilepsy: a case series. |
2020-11-30 |
2023-08-13 |
Not clear |
| b' Chiara Pane, Francesco Sacc\\xc3\\xa. The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 41. issue 3. 2020-11-30. PMID:31776867.' |
in italy, medical grade cannabis (mgc) can be prescribed for different medical conditions, including drug-resistant epilepsy (dre), once standard and approved therapies have failed, or caused non-tolerable side effects. |
2020-11-30 |
2023-08-13 |
Not clear |
| Han Li, Yuzhi Liu, Danni Tian, Lei Tian, Xingke Ju, Liang Qi, Yongbo Wang, Chengyuan Lian. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease. European journal of medicinal chemistry. vol 192. 2020-11-30. PMID:32109623. |
overview of cannabidiol (cbd) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and alzheimer's disease. |
2020-11-30 |
2023-08-13 |
Not clear |
| Melody Rya. Cannabidiol in epilepsy: The indications and beyond. The mental health clinician. vol 10. issue 6. 2020-11-24. PMID:33224689. |
cannabidiol in epilepsy: the indications and beyond. |
2020-11-24 |
2023-08-13 |
Not clear |
| Melody Rya. Cannabidiol in epilepsy: The indications and beyond. The mental health clinician. vol 10. issue 6. 2020-11-24. PMID:33224689. |
this article examines 3 cases: 1 of a patient with lennox-gastaut syndrome, 1 of off-label use of cannabidiol to treat epilepsy, and 1 of nonprescription forms of cannabidiol to treat epilepsy. |
2020-11-24 |
2023-08-13 |
Not clear |
| Guilherme Diogo Silva, Felipe Borelli Del Guerra, Maira de Oliveira Lelis, Lécio Figueira Pint. Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps. Frontiers in neurology. vol 11. 2020-11-17. PMID:33192966. |
cannabidiol in the treatment of epilepsy: a focused review of evidence and gaps. |
2020-11-17 |
2023-08-13 |
Not clear |
| Lieven Laga. Long-term effects of cannabinoids on development/behaviour. Epileptic disorders : international epilepsy journal with videotape. vol 22. issue S1. 2020-11-02. PMID:31908315. |
cannabis-derived products such as cannabidiol are now increasingly prescribed for different refractory childhood epilepsy syndromes. |
2020-11-02 |
2023-08-13 |
Not clear |
| Rima Nabbout, Elizabeth A Thiel. The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials. Epileptic disorders : international epilepsy journal with videotape. vol 22. issue S1. 2020-11-02. PMID:31916540. |
however, several reports of small series or case reports of the use of cannabis extracts in epilepsy yielded contradictory results and the efficacy of cannabis use in patients with epilepsy have also been inconclusive. |
2020-11-02 |
2023-08-13 |
Not clear |
| Alexis Arzimanoglou, Ulrich Brandl, J Helen Cross, Antonio Gil-Nagel, Lieven Lagae, Cecilie Johannessen Landmark, Nicola Specchio, Rima Nabbout, Elizabeth A Thiele, Oliver Gubbay, The Cannabinoids International Experts Pane. Epilepsy and cannabidiol: a guide to treatment. Epileptic disorders : international epilepsy journal with videotape. vol 22. issue 1. 2020-11-02. PMID:32096470. |
epilepsy and cannabidiol: a guide to treatment. |
2020-11-02 |
2023-08-13 |
Not clear |
| Marcella Gherzi, Giulia Milano, Carmen Fucile, Maria Grazia Calevo, Maria Margherita Mancardi, Lino Nobili, Pietro Astuni, Valeria Marini, Sebastiano Barco, Giuliana Cangemi, Luca Manfredini, Francesca Mattioli, Elisa De Grandi. Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy. Complementary therapies in medicine. vol 51. 2020-11-02. PMID:32507423. |
to evaluate safety and pharmacokinetic parameters (pk) of medical cannabis in add-on for children and young adults with drug-resistant epilepsy. |
2020-11-02 |
2023-08-13 |
Not clear |
| Ana Paula de A Boleti, Breno Emanuel F Frihling, Patrícia Souza E Silva, Pedro Henrique de O Cardoso, Luiz Filipe R N de Moraes, Thiago Antônio A Rodrigues, Maria Eduarda Freitas Biembengute, Hector Henrique F Koolen, Ludovico Migliol. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy. Neuroscience and biobehavioral reviews. 2020-11-01. PMID:33031814. |
biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy. |
2020-11-01 |
2023-08-13 |
Not clear |
| Ana Paula de A Boleti, Breno Emanuel F Frihling, Patrícia Souza E Silva, Pedro Henrique de O Cardoso, Luiz Filipe R N de Moraes, Thiago Antônio A Rodrigues, Maria Eduarda Freitas Biembengute, Hector Henrique F Koolen, Ludovico Migliol. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy. Neuroscience and biobehavioral reviews. 2020-11-01. PMID:33031814. |
cannabidiol (cbd) is a major active component of the cannabis plant and the source of cbd-enriched products for the treatment of epilepsy and associated diseases. |
2020-11-01 |
2023-08-13 |
Not clear |
| Umberto Raucci, Nicola Pietrafusa, Maria Chiara Paolino, Giovanni Di Nardo, Maria Pia Villa, Piero Pavone, Gianluca Terrin, Nicola Specchio, Pasquale Striano, Pasquale Paris. Cannabidiol Treatment for Refractory Epilepsies in Pediatrics. Frontiers in pharmacology. vol 11. 2020-10-30. PMID:33117180. |
cannabidiol treatment for refractory epilepsies in pediatrics. |
2020-10-30 |
2023-08-13 |
Not clear |
| Umberto Raucci, Nicola Pietrafusa, Maria Chiara Paolino, Giovanni Di Nardo, Maria Pia Villa, Piero Pavone, Gianluca Terrin, Nicola Specchio, Pasquale Striano, Pasquale Paris. Cannabidiol Treatment for Refractory Epilepsies in Pediatrics. Frontiers in pharmacology. vol 11. 2020-10-30. PMID:33117180. |
cannabis extracts in oil are becoming increasingly available, and, during the last years, there has been growing public and scientific interest about therapeutic properties of these compounds for the treatment of several neurologic diseases, not just epilepsy. |
2020-10-30 |
2023-08-13 |
Not clear |
| Lisa Morrow, Zoe Belsha. Does the addition of cannabidiol to conventional antiepileptic drug treatment reduce seizure frequency in dogs with epilepsy? The Veterinary record. vol 186. issue 15. 2020-10-29. PMID:32358117. |
does the addition of cannabidiol to conventional antiepileptic drug treatment reduce seizure frequency in dogs with epilepsy? |
2020-10-29 |
2023-08-13 |
Not clear |
| Renandro de Carvalho Reis, Kelson James Almeida, Luciano da Silva Lopes, Cíntia Maria de Melo Mendes, Edson Bor-Seng-Sh. Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis. Epilepsy & behavior : E&B. vol 102. 2020-10-19. PMID:31731110. |
efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: systematic review and meta-analysis. |
2020-10-19 |
2023-08-13 |
Not clear |
| Renandro de Carvalho Reis, Kelson James Almeida, Luciano da Silva Lopes, Cíntia Maria de Melo Mendes, Edson Bor-Seng-Sh. Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis. Epilepsy & behavior : E&B. vol 102. 2020-10-19. PMID:31731110. |
we used the terms ("cannabidiol" or "cannabis") and "epilepsy" and ("treatment" or "therapeutics") as keywords to retrieve studies indexed on pubmed, sciencedirect, and central databases. |
2020-10-19 |
2023-08-13 |
Not clear |
| Michelle Markle, Donna G Nativi. Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. vol 33. issue 6. 2020-10-13. PMID:31160106. |
this article discusses the controversial but promising topic of medical marijuana (mm) use in the pediatric population with epilepsy. |
2020-10-13 |
2023-08-13 |
Not clear |